Inventor · disambiguated record
Michael V. Templin
Also filed as: TEMPLIN MICHAEL V
5 granted patents·14 pending applications·77 citations·filing 1997–2017
80Inventor score
Files withMARINA BIOTECH INC5ISIS PHARMACEUTICALS INC4NASTECH PHARM CO3MDRNA INC2ARCTURUS THERAPEUTICS INC1
Top patents by PatentIndex Score
19 records- 0188US7964579B2Compositions and methods for topical delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2009·Granted Jun 21, 2011·4 cites·43 claims
- 0284US6841539B1Compositions and methods for topical delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1999·Granted Jan 11, 2005·52 cites·1 claims
- 0369US9340789B2UNA oligomer structures for therapeutic agentsTEMPLIN MICHAEL V·Filed 2009·Granted May 17, 2016·2 cites·9 claims
- 0467US10023863B2Therapeutics with conformationally restricted monomersMARINA BIOTECH INC·Filed 2015·Granted Jul 17, 2018·1 cites·10 claims
- 0563US2005096287A1Compositions and methods for topical delivery of oligonucleotidesFiled 2004·Application pending·0 cites
- 0662US2010112042A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMDRNA INC·Filed 2009·Application pending·0 cites
- 0757US2009042823A1Uses of broad spectrum rnai therapeutics against influenzaMDRNA INC·Filed 2008·Application pending·0 cites
- 0857US2015073038A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 0956US6083923ALiposomal oligonucleotide compositions for modulating RAS gene expressionISIS PHARMACEUTICALS INC·Filed 1997·Granted Jul 4, 2000·18 cites·4 claims
- 1054US2008318837A1Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating PeptideNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 1153US2011213014A1Compositions and methods for topical delivery of oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 1253US2008051332A1Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormoneNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 1351US2013039970A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMARINA BIOTECH INC·Filed 2012·Application pending·0 cites
- 1451US2017216227A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 1547US2012277289A1Activity generating delivery moleculesFAM RENATA·Filed 2010·Application pending·0 cites
- 1645US2015209283A1Processes and compositions for liposomal and efficient delivery of gene silencing therapeuticsMARINA BIOTECH INC·Filed 2015·Application pending·0 cites
- 1744US2009220435A1Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agentsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 1843US2013190383A1Nucleic acid compounds with conformationally restricted monomers and uses thereofVAISH NARENDRA K·Filed 2011·Application pending·0 cites
- 1942US2016215293A1Una oligomer active structures for therapeutic agentsARCTURUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael V. Templin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →